Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors
Xunlei Kang, Jaehyup Kim, Mi Deng, et al.
Cell Cycle (2015) Vol. 15, Iss. 1, pp. 25-40
Open Access | Times Cited: 174

Showing 1-25 of 174 citing articles:

Phagocytosis checkpoints as new targets for cancer immunotherapy
Mingye Feng, Wen Jiang, Betty Y.S. Kim, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 568-586
Open Access | Times Cited: 741
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Rui Su, Lei Dong, Yangchan Li, et al.
Cancer Cell (2020) Vol. 38, Iss. 1, pp. 79-96.e11
Open Access | Times Cited: 576
Combination strategies to maximize the benefits of cancer immunotherapy
Shaoming Zhu, Tian Zhang, Lei Zheng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 421
NK Cell-Based Immune Checkpoint Inhibition
Muhammad Khan, Sumbal Arooj, Hua Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 274
LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration
Mi Deng, Xun Gui, Jaehyup Kim, et al.
Nature (2018) Vol. 562, Iss. 7728, pp. 605-609
Open Access | Times Cited: 229
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
Hao Wang, Gurbakhash Kaur, Alexander Sankin, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 152
Emerging phagocytosis checkpoints in cancer immunotherapy
Yue Liu, Yanjin Wang, Yanrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 143
A physical wiring diagram for the human immune system
Jarrod Shilts, Yannik Severin, Francis Galaway, et al.
Nature (2022) Vol. 608, Iss. 7922, pp. 397-404
Open Access | Times Cited: 89
LILRB receptor-mediated regulation of myeloid cell maturation and function
William van der Touw, Hui-Ming Chen, Ping‐Ying Pan, et al.
Cancer Immunology Immunotherapy (2017) Vol. 66, Iss. 8, pp. 1079-1087
Open Access | Times Cited: 124
NK cells in autoimmune diseases: Linking innate and adaptive immune responses
Elena Gianchecchi, Domenico Vittorio Delfino, Alessandra Fierabracci
Autoimmunity Reviews (2017) Vol. 17, Iss. 2, pp. 142-154
Closed Access | Times Cited: 117
A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML
Samuel John, Heyu Chen, Mi Deng, et al.
Molecular Therapy (2018) Vol. 26, Iss. 10, pp. 2487-2495
Open Access | Times Cited: 107
Next frontier in tumor immunotherapy: macrophage-mediated immune evasion
Yingqi Qiu, Tong Chen, Rong Hu, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 99
Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model
Jinchao Hou, Yun Chen, Zhangying Cai, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 741
Closed Access | Times Cited: 14
Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules
Ali Hazrati, Kosar Malekpour, Hossein Khorramdelazad, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Maternal and fetal T cells in term pregnancy and preterm labor
Derek Miller, Meyer Gershater, Rebecca Slutsky, et al.
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 7, pp. 693-704
Open Access | Times Cited: 68
Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development
Xun Gui, Mi Deng, Hao Song, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 8, pp. 1244-1257
Open Access | Times Cited: 67
IL-13–regulated Macrophage Polarization during Granuloma Formation in anIn VitroHuman Sarcoidosis Model
Landon W. Locke, Elliott D. Crouser, Peter White, et al.
American Journal of Respiratory Cell and Molecular Biology (2018) Vol. 60, Iss. 1, pp. 84-95
Open Access | Times Cited: 65
Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion
Daeun Ryu, Seok Jin Kim, Yourae Hong, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 4, pp. 935-944
Open Access | Times Cited: 64
HLA-G Neo-Expression on Tumors
Maria Loustau, François Anna, Raphaelle Dréan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells
Zunling Li, Mi Deng, Fangfang Huang, et al.
Cellular and Molecular Immunology (2019) Vol. 17, Iss. 3, pp. 272-282
Open Access | Times Cited: 56
ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells
Latika Singh, Eric S. Muise, Anannya Bhattacharya, et al.
Molecular Cancer Research (2020) Vol. 19, Iss. 4, pp. 702-716
Open Access | Times Cited: 56
Alterations of T-cell-mediated immunity in acute myeloid leukemia
Zhuoyan Li, Mary Philip, P. Brent Ferrell
Oncogene (2020) Vol. 39, Iss. 18, pp. 3611-3619
Open Access | Times Cited: 52
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45
Detection of Immune Checkpoint Receptors – A Current Challenge in Clinical Flow Cytometry
Benjamin GT Shibru, Katharina Fey, Stephan Fricke, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top